Filter Results :

Your search for T-cell returned 29 reports

Sort by


T-Cell Leukemia-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary T-Cell Leukemia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T-Cell Leukemia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Peripheral T-Cell Lymphomas (PTCL)-API Insights, 2015,report provides Peripheral T-Cell Lymphomas (PTCL) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF)...

$ 1,250.00

Read More

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Leukemia-API Insights, 2015,report provides T-Cell Leukemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00

Read More

T-Cell Lymphomas-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary T-Cell Lymphomas- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T-Cell Lymphomas. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing dea...

$ 1,250.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Lymphomas-API Insights, 2015,report provides T-Cell Lymphomas drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cutaneous T-Cell Lymphoma-API Insights, 2015,report provides Cutaneous T-Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Cutaneous T-Cell Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cutaneous T-Cell Lymphoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Peripheral T-Cell Lymphomas (PTCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Peripheral T-Cell Lymphomas (PTCL). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

28 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stage...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

24 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with comparativ...

$ 2,000.00

Read More

T-Cell Leukemia - Pipeline Review, H1 2015

24 Feb 2015  |  Published by:  Global Markets Direct
Summary‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by ...

$ 2,000.00

Read More

T-Cell Lymphomas - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘T-Cell Lymphomas - Pipeline Review, H2 2014’, provides an overview of the T-Cell Lymphomas’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for T-Cell Lymphomas, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014

31 Oct 2014  |  Published by:  Global Markets Direct
Summary‘Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stage...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'Peripheral T-Cell Lymphomas (PTCL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understand...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'Cutaneous T-Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for A...

$ 2,000.00

Read More
Total 29 records.